medicare coverage b12 injections Methylcobalamin Injection (Vitamin B12) I have a prescription for

The FDA's 2023 briefing to the Pharmacy Compounding Advisory Committee cited the lack of sufficient clinical evidence for therapeutic compounding approval

The answer depends on the endpoint

(Hurley & Frier, 2025) For patients, this means the first question to ask of any provider offering peptide therapy isn't "do you offer peptides" but "how are you sourcing them and what is the current regulatory status of each compound you prescribe?" A provider still listing Category 2 compounds as standard menu offerings without discussing compounding compliance is telling you something important about their regulatory literacy

These shots are prescribed by a doctor and given to your muscles